Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:SNN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeSNNSmith & Nephew SNATS$30.14+0.9%$29.48$23.69▼$31.72$13.09B0.69817,624 shs724,590 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceSNNSmith & Nephew SNATS+1.08%-3.71%+4.54%+15.43%+5.90%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationSNNSmith & Nephew SNATS2.8946 of 5 stars1.03.02.50.02.20.04.4Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceSNNSmith & Nephew SNATS 2.00Hold$28.00-7.10% DownsideCurrent Analyst Ratings BreakdownLatest PCGH, BHMU, SNN, and FEV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/1/2025SNNSmith & Nephew SNATSCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$27.00 ➝ $28.004/25/2025SNNSmith & Nephew SNATSHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/25/2025SNNSmith & Nephew SNATSHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookSNNSmith & Nephew SNATS$5.81B2.27$3.18 per share9.47$12.04 per share2.50Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateSNNSmith & Nephew SNATS$412M$2.1613.9515.070.91N/AN/AN/A8/5/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthSNNSmith & Nephew SNATS$0.892.95%N/A41.20%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioSNNSmith & Nephew SNATS0.622.891.33Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipSNNSmith & Nephew SNATS25.64%Insider OwnershipCompanyInsider OwnershipSNNSmith & Nephew SNATS1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableSNNSmith & Nephew SNATS17,349437.97 million433.59 millionOptionablePCGH, BHMU, SNN, and FEV HeadlinesRecent News About These CompaniesEnvestnet Asset Management Inc. Raises Holdings in Smith & Nephew SNATS, Inc. (NYSE:SNN)July 18 at 3:27 AM | marketbeat.comBrokerages Set Smith & Nephew SNATS, Inc. (NYSE:SNN) PT at $28.00July 12, 2025 | americanbankingnews.comSNN or ESLOY: Which Is the Better Value Stock Right Now?July 11, 2025 | zacks.comAre Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?July 11, 2025 | zacks.comAllspring Global Investments Holdings LLC Invests $335,000 in Smith & Nephew SNATS, Inc. (NYSE:SNN)July 11, 2025 | marketbeat.comSmith & Nephew SNATS (NYSE:SNN) Sees Large Volume Increase - Here's What HappenedJuly 9, 2025 | marketbeat.comCallan Capital LLC Takes Position in Smith & Nephew SNATS, Inc. (NYSE:SNN)July 9, 2025 | marketbeat.comSmith & Nephew SNATS, Inc. (NYSE:SNN) Receives Consensus Rating of "Hold" from AnalystsJuly 9, 2025 | marketbeat.comSmith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless optionJuly 7, 2025 | globenewswire.comSmith & Nephew SNATS, Inc. (NYSE:SNN) Shares Acquired by Oppenheimer Asset Management Inc.June 28, 2025 | marketbeat.comSNN Expands Orthopedic Portfolio With Advanced Tibia Nailing SystemJune 26, 2025 | zacks.comSNN vs. GEHC: Which Stock Is the Better Value Option?June 25, 2025 | zacks.comIs Smith & Nephew SNATS (SNN) Stock Undervalued Right Now?June 25, 2025 | zacks.comSmith & Nephew SNATS (NYSE:SNN) Sees Unusually-High Trading Volume - Time to Buy?June 24, 2025 | marketbeat.comSmith+Nephew's new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing' to trauma surgeons repairing tibial fracturesJune 24, 2025 | globenewswire.comScharf Investments LLC Sells 555,004 Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN)June 23, 2025 | marketbeat.comAjay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy OfficerJune 23, 2025 | globenewswire.comSmith+Nephew Stock May Gain From Strategic Deal With Standard HealthJune 20, 2025 | zacks.comSmith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UKJune 18, 2025 | globenewswire.comNew medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatilityJune 9, 2025 | globenewswire.comSmith & Nephew (SN) Receives a Buy from CitiJune 7, 2025 | theglobeandmail.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePCGH, BHMU, SNN, and FEV Company DescriptionsSmith & Nephew SNATS NYSE:SNN$30.14 +0.26 (+0.87%) Closing price 03:59 PM EasternExtended Trading$30.17 +0.03 (+0.11%) As of 05:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.